The company specializes in developing innovative inhalation products using its unique electrohydrodynamic (EHD) aerosolization and formulation technologies. Ventaira Pharmaceuticals focuses on creating inhaled drugs like fentanyl for breakthrough pain treatment and salmeterol for asthma management. By harnessing its proprietary EHD aerosolization method, the company aims to enhance drug delivery and improve patient outcomes.